<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: red blood cell</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Single, high-dose erythropoietin given two days pre-op reduces need for transfused blood</title>
   	 <description>Anemia increases operative mortality and morbidity in non-cardiac and cardiac surgical procedures. Anemic surgical patients may require more blood transfusions, raising the risk of transfusion-related complications and increasing costs. For those reasons, optimizing patient readiness by correcting anemia prior to surgery is an important clinical goal. A simple new protocol has been proposed that helps correcting anemia using a single, high dose of recombinant human erythropoietin (HRE) administered only two days prior to surgery. The results of a randomized study will be presented by Luca Weltert, MD, Cardiac Surgery Department of the European Hospital in Rome, during the Plenary Scientific Session of the 93rd AATS Annual Meeting in Minneapolis.</description>
     <link>http://medicalxpress.com/news/2013-05-high-dose-erythropoietin-days-pre-op-transfused.html</link>
	 <category>Surgery</category>
	 <pubDate>Mon, 06 May 2013 10:49:37 EST</pubDate>
	 <guid isPermaLink="false">news287056166</guid>
	 
</item>
<item>
     <title>Researchers find that simple blood test can help identify trauma patients at greatest risk of death</title>
   	 <description>A simple, inexpensive blood test performed on trauma patients upon admission can help doctors easily identify patients at greatest risk of death, according to a new study by researchers at Intermountain Medical Center in Salt Lake City.</description>
     <link>http://medicalxpress.com/news/2013-01-simple-blood-trauma-patients-greatest.html</link>
	 <category>Health</category>
	 <pubDate>Fri, 18 Jan 2013 00:20:01 EST</pubDate>
	 <guid isPermaLink="false">news277661804</guid>
	 
</item>
<item>
     <title>Researchers link new molecular culprit to breast cancer progression</title>
   	 <description>(Phys.org)—Johns Hopkins researchers have uncovered a protein &quot;partner&quot; commonly used by breast cancer cells to unlock genes needed for spreading the disease around the body. A report on the discovery, published November 5 on the website of the Proceedings of the National Academy of Sciences, details how some tumors get the tools they need to metastasize.</description>
     <link>http://medicalxpress.com/news/2012-11-link-molecular-culprit-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 25 Nov 2012 07:30:01 EST</pubDate>
	 <guid isPermaLink="false">news273049193</guid>
	 
</item>
<item>
     <title>Researchers work to improve efficacy of blood transfusions for preterm babies</title>
   	 <description>(Medical Xpress)—Results of new research from the University of Adelaide are a promising step forward in helping to improve the quality of life-saving blood transfusions for preterm babies, by reducing the likelihood of adverse inflammatory responses to the blood.</description>
     <link>http://medicalxpress.com/news/2012-11-efficacy-blood-transfusions-preterm-babies.html</link>
	 <category>Pediatrics</category>
	 <pubDate>Thu, 22 Nov 2012 08:40:03 EST</pubDate>
	 <guid isPermaLink="false">news272795237</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/betterbloodt.jpg" width="90" height="90" />
</item>
<item>
     <title>Duke research team identifies a potent growth factor for blood stem cells</title>
   	 <description>Duke Medicine researchers studying the interaction of blood stem cells and the niche where they reside have identified a protein that may be a long-sought growth factor for blood stem cells.</description>
     <link>http://medicalxpress.com/news/2012-10-duke-team-potent-growth-factor.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 23 Oct 2012 10:30:01 EST</pubDate>
	 <guid isPermaLink="false">news270203970</guid>
	 
</item>
<item>
     <title>Putting a block on neuropathic pain before it starts</title>
   	 <description>Using tiny spheres filled with an anesthetic derived from a shellfish toxin, researchers at Boston Children's Hospital and the Massachusetts Institute of Technology have developed a way to delay the rise of neuropathic pain, a chronic form of pain that arises from flawed signals transmitted by damaged nerves.</description>
     <link>http://medicalxpress.com/news/2012-10-block-neuropathic-pain.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 09 Oct 2012 10:52:28 EST</pubDate>
	 <guid isPermaLink="false">news268998715</guid>
	 
</item>
<item>
     <title>Supplement use predicts folate status in Canadian women</title>
   	 <description>Researchers have gained new insight into why 22% of Canadian women of childbearing age are still not achieving a folate concentration considered optimal for reducing the risk of having babies with neural tube defects, despite a virtual absence of folate deficiency in the general Canadian population.</description>
     <link>http://medicalxpress.com/news/2012-04-supplement-folate-status-canadian-women.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 10 Apr 2012 10:34:30 EST</pubDate>
	 <guid isPermaLink="false">news253272860</guid>
	 
</item>
<item>
     <title>Duration of RBC storage does not affect short-term pulmonary, immunologic, or coagulation status</title>
   	 <description>There is no difference in early measures of pulmonary function, immunologic status or coagulation status after fresh versus standard issue single-unit red blood cell (RBC) transfusion, according to a new study from the Mayo Clinic.</description>
     <link>http://medicalxpress.com/news/2012-01-duration-rbc-storage-affect-short-term.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 20 Jan 2012 04:40:03 EST</pubDate>
	 <guid isPermaLink="false">news246254418</guid>
	 
</item>
<item>
     <title>Fixing common blood disorder would make kidney transplants more successful</title>
   	 <description>Correcting anemia, a red blood cell deficiency, can preserve kidney function in many kidney transplant recipients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results indicate that aggressively treating anemia may help save the kidneys&amp;#151;and possibly the lives&amp;#151;of many transplant recipients.</description>
     <link>http://medicalxpress.com/news/2011-12-common-blood-disorder-kidney-transplants.html</link>
	 <category>Other</category>
	 <pubDate>Thu, 22 Dec 2011 18:21:31 EST</pubDate>
	 <guid isPermaLink="false">news243800434</guid>
	 
</item>
<item>
     <title>Long non-coding RNA prevents the death of maturing red blood cells</title>
   	 <description>A long non-coding RNA (lncRNA) regulates programmed cell death during one of the final stages of red blood cell differentiation, according to Whitehead Institute researchers. This is the first time a lncRNA has been found to play a role in red blood cell development and the first time a lncRNA has been shown to affect programmed cell death.</description>
     <link>http://medicalxpress.com/news/2011-12-non-coding-rna-death-maturing-red.html</link>
	 <category>Genetics</category>
	 <pubDate>Wed, 07 Dec 2011 17:00:05 EST</pubDate>
	 <guid isPermaLink="false">news242497738</guid>
	 
</item>
<item>
     <title>Engineered, drug-secreting blood vessels reverse anemia in mice</title>
   	 <description>Patients who rely on recombinant, protein-based drugs must often endure frequent injections, often several times a week, or intravenous therapy. Researchers at Children's Hospital Boston demonstrate the possibility that blood vessels, made from genetically engineered cells, could secrete the drug on demand directly into the bloodstream. In the November 17 issue of the journal Blood, they provide proof-of-concept, reversing anemia in mice with engineered vessels secreting erythropoietin (EPO).</description>
     <link>http://medicalxpress.com/news/2011-11-drug-secreting-blood-vessels-reverse-anemia.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 15 Nov 2011 16:27:32 EST</pubDate>
	 <guid isPermaLink="false">news240596839</guid>
	 
</item>
<item>
     <title>Transfusion not always best treatment for anemia, age of stored blood may play a role</title>
   	 <description>University of Kentucky researchers, including lead author Samy Selim of the Division of Cardiovascular Medicine and the Saha Cardiovascular Research Center, have recently published a paper suggesting that transfusion may not always be the best treatment for hospitalized patients with anemia. Results suggest the age of stored blood may be a factor in negative effects of transfusion.</description>
     <link>http://medicalxpress.com/news/2011-10-transfusion-treatment-anemia-age-blood.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 12 Oct 2011 12:47:07 EST</pubDate>
	 <guid isPermaLink="false">news237642414</guid>
	 
</item>
<item>
     <title>Blood loss from lab testing associated with hospital-acquired anemia for patients with heart attacks</title>
   	 <description>In patients with acute myocardial infarction (heart attack), blood loss from greater use of phlebotomy (blood drawn for diagnostic testing) appears to be independently associated with the development of hospital-acquired anemia (HAA), according to a report published Online First by Archives of Internal Medicine, one of the JAMA/Archives journals. The article is part of the journal's Less Is More series.</description>
     <link>http://medicalxpress.com/news/2011-08-blood-loss-lab-hospital-acquired-anemia.html</link>
	 <category>Other</category>
	 <pubDate>Mon, 08 Aug 2011 16:30:01 EST</pubDate>
	 <guid isPermaLink="false">news232030996</guid>
	 
</item>
<item>
     <title>Study examines outcomes of erythropoietin use for heart attack patients undergoing PCI</title>
   	 <description>Intravenous administration of epoetin alfa, a product that stimulates red blood cell production, to patients with heart attack who were undergoing percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), did not provide reduction in the size of the heart muscle involved and was associated with higher rates of adverse cardiovascular events, according to a study in the May 11 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2011-05-outcomes-erythropoietin-heart-patients-pci.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 10 May 2011 16:25:29 EST</pubDate>
	 <guid isPermaLink="false">news224263508</guid>
	 
</item>


</channel>
</rss>
